Selecting Optimal Formulation Technology for Better Patient Treatment
Summary: This article originally published in ONdrugDelivery Magazine, highlights lipid-based formulations for better patient treatment. Stephen Tindal, Director, Scientific Affairs, Catalent Pharma Solutions, provides insights into Catalent’s strategies for oral formulation selection which can lower attrition rates, and therefore development costs and time to market.